Links to Studies

Status Official Title Lead Investigator Last Updated
Finalised Background rates of Adverse Events of Special Interest for monitoring COVID-19 vaccines Professor Miriam Sturkenboom 09/01/2023
Finalised ACCESS template protocol for safety of COVID-19 vaccines Professor Miriam Sturkenboom 09/01/2023
Finalised Drug usage patterns of Pylera® in France using the national claims reimbursement database Professor Nicholas Moore 16/12/2022
Finalised Alert generation using the case-population approach in the French claims databases Professor Nicholas Moore 25/11/2022
Finalised Effectiveness of Tecfidera® in multiple sclerosis: a French cohort within the nationwide claims and hospital database Dr Patrick Blin 24/11/2022
Finalised Assessment of Oralair® use in real-life Dr Patrick Blin 24/11/2022
Finalised Budget impact analysis of discontinuing Tyrosin Kinase Inhibitors in patients with chronic myeloid leukemia achieving a complete molecular response by using probabilistic Markov approach Professor Nicholas MOORE 24/11/2022
Finalised Study of Acute Liver Transplant-III: Prospective study of drug-exposed acute liver failure (ALF) in European liver transplant centers Professor Nicholas MOORE 24/11/2022
Finalised Resistant Depression in France, description from the nationwide claims and hospitalization database Dr Nicholas Moore 23/11/2022
Finalised Use of Selincro® and impact on usual practice Professor Nicholas Moore 22/11/2022
Finalised Secondary Prevention of Acute Coronary Events with Antiplatelet Agents: A cohort study in the SNIIRAM database Professor Nicholas Moore 22/11/2022
Finalised Health Outcomes, Resource Use, costs in patients with Stable coronary artery disease a cohort study in the EGB database Professor Nicholas Moore 22/11/2022
Finalised Observational study of post-myocardial infarction with a long follow-up Professor Nicholas Moore 22/11/2022
Finalised Real-life anticoagulants benefit-risk in atrial fibrillation (AF) in France: VKA benefit-risk assessment before DOAC use for AF Professor Nicholas Moore 22/11/2022
Finalised Benefit and risk of AntiThrombotic Treatments after Orthopaedic Surgery in real-life settings: a cohort study in the SNIIRAM claims and hospitalisation database Dr Patrick BLIN 18/11/2022
Finalised Incidence, prevalence and burden of Dry Eye diseAse in France Dr Patrick Blin 18/11/2022
Finalised Benefit-risk of arterial thrombotic prevention with rivaroxaban for atrial fibrillation in daily clinical practice Professor Nicholas Moore 18/11/2022
Finalised Real-life anticoagulants comparative benefit-risk in nonvalvular atrial fibrillation (NVAF) in France Professor Nicholas Moore 18/11/2022
Finalised Strengthening Use of Real-World Data in Medicines Development: Metadata for Data Discoverability and Study Replicability Dr Susana Perez-Gutthann 18/10/2022
Finalised Therapeutic strategy in metastatic castration-resistant prostate cancer: target population and changes between 2012 and 2014. Two sequential cohorts within the French nation-wide claims and hospital database Dr Patrick Blin 12/09/2022
Finalised Malignancies in Multiple Sclerosis: Multi-country cohort database studies – French Study Dr Patrick Blin 05/09/2022
Finalised A Safety and Pharmacokinetic study in Real-life practice of Pylera® in France: The SAPHARY study Dr Patrick BLIN 17/05/2022
Finalised Follow-Up of Jevtana® in real lIfe Professor Nicholas Moore 11/05/2022
Finalised Malignancies in Multiple Sclerosis: multi-country cohort database studies (feasibility study) Dr Patrick Blin 05/04/2022
Finalised Assessment of The High risk and unmEt Need in patients with coronary artery disease and type 2 diabetes in France Dr Patrick Blin 05/04/2022
Finalised Characterising the risk of major bleeding in patients with Non-Valvular Atrial Fibrillation: non-interventional study of patients taking Direct Oral Anticoagulants in the EU Dr Helga Gardarsdottir 17/03/2022
Finalised Osteoporosis outcomes and treatment patterns in France (20190017) Dr Pauline Bosco-Levy (Prince) 11/02/2022
Finalised Nurses Internal Contamination by Antineoplastic Drugs Dr Catherine VERDUN-ESQUER 03/02/2022
Finalised Intravenous Iron Postauthorisation Safety Study (PASS): Evaluation of the Risk of Severe Hypersensitivity Reactions Mrs Lia Gutierrez 08/09/2021
Finalised Study of Acute Liver Transplant-II Professor Sinem Ezgi Gulmez 03/05/2021
Finalised Study of Acute Liver Transplant: A study of NSAIDs-exposed acute liver failure in European transplant centres Professor Ezgi Gulmez 03/05/2021
Finalised Glargine and risk of cancer Dr Patrick Blin 03/05/2021
Finalised Real life assessment of chronic obstructive pulmonary disease Inhaler devices handling Professor Mathieu MOLIMARD 01/10/2020
Finalised Epidemiology of acute hepatotoxicity from medicines Professor Sinem Ezgi Gulmez 31/08/2020
Finalised First-line anticancer drugs in patients with advanced, primary Non-Small Cell Lung Cancer: drug-utilization and effectiveness studies from Tuscany Region healthcare database Dr Spini Andrea 08/08/2020
Ongoing Dual antiplatelet therapy for prolonged secondary prevention of acute coronary events Professor Nicholas Moore 23/02/2023
Ongoing Cohort Event Monitoring of safety of COVID-19 vaccines (Early-) Covid-Vaccine-Monitor Dr Agnes Kant 13/10/2022
Ongoing Non-Interventional retrospective longitudinal study in the UK and France to evaluate and identify the best practices for switching of valproate and related substances in clinical practice Dr Pauline Bosco-Levy (Prince) 05/09/2022
Ongoing CONSIGN study: COVID-19 infection and medicines in pregnancy - a multinational registry based study Professor Hedvig Nordeng 16/08/2022
Ongoing Cardiovascular-Renal-Metabolism comorbidity epidemiology and healthcare utilisation – Observational studies across Europe – French part of the study program Dr Patrick Blin 05/04/2022
Ongoing An observational post-authorization safety study to describe the safety of ustekinumab and other treatments of ulcerative colitis in a cohort of patients with ulcerative colitis using the French Nationwide claims database (SNDS) France Dr Patrick Blin 03/02/2022
Ongoing Comparative assessment of venous thromboembolism and other risks among patients with rheumatoid arthritis treated with baricitinib versus tumor necrosis factor inhibitors - French part of the study program Dr Nicolas Thurin 15/10/2021
Ongoing Economic evaluation of Prostatic Urethral Lift (Urolift) Professor Grégoire ROBERT 12/10/2021
Ongoing Economic evaluation of robot-assisted laparoscopic radical prostatectomy vs conventional laparoscopic radical prostatectomy and open retropubic radical prostatectomy in prostate cancer: a real-life study based on the French National Healthcare Data System (SNDS). Ms Nathalie HAYES 12/10/2021
Ongoing Impact of cardiovascular comorbidities on the effectiveness of bevacizumab in elderly patients with metastatic colorectal cancer Dr Amandine Gouverneur 31/05/2021
Ongoing Study on feeling according to the patient of allergens specially prepared for individuals (allergenic ‘Named Patient Products’ NPPs) Dr Patrick Blin 03/05/2021
Ongoing EUROPEAN NON-INTERVENTIONAL POST AUTHORIZATION SAFETY STUDY RELATED TO SERIOUS INFECTIONS FOR ROMOSOZUMAB BY THE EU ADR ALLIANCE Dr Clinical Trial Registries and Results Personal data of lead investigator will not be disclosed because his/her consent required for disclosure according to applicable data protection laws is not available. 29/10/2020
Ongoing EUROPEAN NON-INTERVENTIONAL POST-AUTHORIZATION SAFETY STUDY RELATED TO ADHERENCE TO THE RISK MINIMIZATION MEASURES FOR ROMOSOZUMAB BY THE EU-ADR ALLIANCE Dr Clinical Trial Registries and Results Personal data of lead investigator will not be disclosed because his/her consent required for disclosure according to applicable data protection laws is not available. 29/10/2020
Ongoing European non-interventional post-authorization safety study related to serious cardiovascular events of myocardial infarction and stroke, and all-cause mortality for romosozumab by the EU-ADR Alliance Dr Clinical Trial Registries and Results Personal data of lead investigator will not be disclosed because his/her consent required for disclosure according to applicable data protection laws is not available. 29/10/2020
Ongoing A Retrospective Cohort Study to Assess Drug Utilisation and Long-Term Safety of Galcanezumab in European Patients in the Course of Routine Clinical Care Dr Krista Schroeder 30/07/2020
Planned Programme d’évaluation de la vaccination COVID-19 : Risque d’effets indésirables d’intérêt des différents vaccins et comparaison du bénéfice-risque des vaccins Dr Nicolas Thurin 23/03/2023
Planned A Non-interventional Multi-country Cohort Study to Assess the Safety of EVUSHELD™ (Tixagevimab/Cilgavimab) During Pregnancy Mrs Lecomte Coralie 13/02/2023
Planned Description of international collaboration in the area of medicines use and effects in COVID-19 affected pregnancies (CONSIGN-International)) Professor Miriam Sturkenboom 29/09/2022